BATE KENNETH

CIK 000121023811 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001210238

Recent Transactions

50 trades

Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−14,100→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−16,666→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−14,100→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−8,333→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−26,550→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$480.24/sh−1,763→ 17,439 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-11-05−10,000→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$485.54/sh−1,008→ 7,888 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$487.49/sh−2,775→ 4,286 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-11-05−1,105→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$489.95/sh−933→ 2,657 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$303.79/sh+10,000→ 18,097 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$280.04/sh+1,105→ 19,202 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$9.45/sh+5,470→ 8,097 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$486.73/sh−827→ 7,061 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$489.09/sh−696→ 3,590 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-11-05−5,470→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$484.78/sh−1,931→ 8,896 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$481.13/sh−3,259→ 14,180 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$483.41/sh−2,069→ 10,827 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$482.41/sh−1,284→ 12,896 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-11-05$490.98/sh−30→ 2,627 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$364.24/sh−2,516→ 7,794 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$367.63/sh−1,104→ 3,523 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$366.14/sh−600→ 4,627 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-08-15−10,000→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$365.33/sh−2,567→ 5,227 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$368.56/sh−896→ 2,627 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$363.41/sh−2,317→ 10,310 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-08-15$16.46/sh+10,000→ 12,627 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-06-20+1,290→ 1,290 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-06-20+715→ 2,627 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2025-06-11+26,550→ 26,550 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$355.08/sh−8,545→ 12,529 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-02-27−9,470→ 0 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$353.83/sh−238→ 21,074 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$360.07/sh−216→ 1,912 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$357.27/sh−2,038→ 7,700 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$9.45/sh+4,530→ 21,912 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$359.21/sh−2,024→ 2,128 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-02-27−6,000→ 0 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$111.06/sh+6,000→ 7,912 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$351.99/sh−500→ 21,312 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$358.33/sh−3,548→ 4,152 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$65.06/sh+9,470→ 17,382 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$351.01/sh−100→ 21,812 total
Sale
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2025-02-27$356.51/sh−2,791→ 9,738 total
Exercise/Conversion
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2025-02-27−4,530→ 5,470 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Stock Option (Right to Buy)
2024-06-25+1,105→ 1,105 total
Award
MADRIGAL PHARMACEUTICALS, INC.$MDGL
Common Stock
2024-06-25+714→ 1,912 total

Companies

Recent Filings

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210

View on SEC.gov